Dali Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dali Han has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Guanghao Liang
China National Center for Bioinformation, Beijing Institute of Genomics, Chinese Academy of Sciences 3 Department of Computational Biology, Key Laboratory of RNA Science and Engineering Beijing
15 shared publications - Jian Li
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China
14 shared publications - Lin Shen
Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China
14 shared publications - Cheng Liu
Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China
13 shared publications - Cheng Zhang
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China
13 shared publications - Gehan Xu
Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China
13 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Springer Nature in Genome Biology
- Vol. 27 (1) , 236
IDEAL-Age: an interpretable deep learning framework for single-cell resolution profiling of immunological aging
Immunosenescence increases susceptibility to infection and reduces vaccine responsiveness, yet bulk transcriptomic clocks obscure the cellular heterogeneit
- 27 July 2026
- Published by Springer Nature in Genome Biology
- Vol. 27 (1) , 236
Open AccessIDEAL-Age: an interpretable deep learning framework for single-cell resolution profiling of immunological aging
Immunosenescence increases susceptibility to infection and reduces vaccine responsiveness, yet bulk transcriptomic clocks obscure the cellular heterogeneit
- Open Access
- 12 May 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (6)
PRECISE-seq reveals disease-relevant TCR repertoires with phenotypic plasticity
Linking T cell phenotypes with antigen specificity and functional avidity is critical for understanding in vivo immune responses in infection and cancer. Here, we develop PRECISE-seq, a method that integrates multi-omics T cell analysis with contact-dependent proximity labeling for rapid screening of disease-relevant T cell repertoires, and for linking the relative TCR avidity with T cell phenotypes at single-cell resolution. PRECISE-seq accurately retrieves CMV-specific clonotypes from human peripheral blood and quantitatively measures functional avidity in physiological contexts. We find that high-potency CMV-specific T cells preferentially acquire an exhausted phenotype. In tumors, polyclonal tumor-reactive CD8+ T cells predominantly differentiate into a protumor Ly49+ regulatory state (TLy49), characterized by inhibitory killer cell lectin-like receptor expression and originating from effector memory T cells along a trajectory distinct from exhaustion. Notably, PD-1 blockade reduces TLy49 formation and promotes effector revival, which correlates with responsiveness to immunotherapy. Together, PRECISE-seq enables high-resolution mapping of TCR potency and T cell phenotype, revealing a regulatory axis shaping T cell fate in tumors.
- 12 May 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (6)
Open AccessPRECISE-seq reveals disease-relevant TCR repertoires with phenotypic plasticity
Linking T cell phenotypes with antigen specificity and functional avidity is critical for understanding in vivo immune responses in infection and cancer. Here, we develop PRECISE-seq, a method that integrates multi-omics T cell analysis with contact-dependent proximity labeling for rapid screening of disease-relevant T cell repertoires, and for linking the relative TCR avidity with T cell phenotypes at single-cell resolution. PRECISE-seq accurately retrieves CMV-specific clonotypes from human peripheral blood and quantitatively measures functional avidity in physiological contexts. We find that high-potency CMV-specific T cells preferentially acquire an exhausted phenotype. In tumors, polyclonal tumor-reactive CD8+ T cells predominantly differentiate into a protumor Ly49+ regulatory state (TLy49), characterized by inhibitory killer cell lectin-like receptor expression and originating from effector memory T cells along a trajectory distinct from exhaustion. Notably, PD-1 blockade reduces TLy49 formation and promotes effector revival, which correlates with responsiveness to immunotherapy. Together, PRECISE-seq enables high-resolution mapping of TCR potency and T cell phenotype, revealing a regulatory axis shaping T cell fate in tumors.
- Open Access
- 20 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Ultra-precision deconvolution of spatial transcriptomics decodes immune heterogeneity and fate-defining programs in tissues
Elucidating the spatial organization and functional specialization of immune cells within complex tissues remains challenging. We present UCASpatial, an ultra-precision spatial transcriptomics deconvolution algorithm utilizing entropy-based weighting to accurately map cell subpopulations. Benchmarking confirms its superiority in identifying low-abundant cell subpopulations and distinguishing transcriptionally heterogeneous cell subpopulations. Applying UCASpatial to human colorectal cancer, we reveal that chromosome 20q gain in individual cancer clones orchestrates a T cell-excluded microenvironment, associated with HERV-H silencing and impaired type I interferon responses. In murine wound healing models, we reveal spatiotemporal dynamics distinguishing scarring from regenerative phenotypes. Specifically, we identify a pro-fibrotic community comprising Igfbp5+ chondrocytes, Cd36+ Gpnmb+ Il1b- macrophages, and Fmod+ fibroblasts in scarring-healing mice (C57BL/6). We further demonstrate that IL11-IL11RA signaling within this triad drives the pro-fibrotic community formation and limits regeneration. Together, UCASpatial serves as a versatile tool for deciphering fine-grained cellular landscapes and exploring intercellular mechanisms in complex and dynamic microenvironments.
- 20 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessUltra-precision deconvolution of spatial transcriptomics decodes immune heterogeneity and fate-defining programs in tissues
Elucidating the spatial organization and functional specialization of immune cells within complex tissues remains challenging. We present UCASpatial, an ultra-precision spatial transcriptomics deconvolution algorithm utilizing entropy-based weighting to accurately map cell subpopulations. Benchmarking confirms its superiority in identifying low-abundant cell subpopulations and distinguishing transcriptionally heterogeneous cell subpopulations. Applying UCASpatial to human colorectal cancer, we reveal that chromosome 20q gain in individual cancer clones orchestrates a T cell-excluded microenvironment, associated with HERV-H silencing and impaired type I interferon responses. In murine wound healing models, we reveal spatiotemporal dynamics distinguishing scarring from regenerative phenotypes. Specifically, we identify a pro-fibrotic community comprising Igfbp5+ chondrocytes, Cd36+ Gpnmb+ Il1b- macrophages, and Fmod+ fibroblasts in scarring-healing mice (C57BL/6). We further demonstrate that IL11-IL11RA signaling within this triad drives the pro-fibrotic community formation and limits regeneration. Together, UCASpatial serves as a versatile tool for deciphering fine-grained cellular landscapes and exploring intercellular mechanisms in complex and dynamic microenvironments.
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S1 Verification of high-metastasis mouse model and the relationship between SPP1 and clinical features. A-F Results of bright field imaging, migration, and invasion assays for LoVo, LoVo-HM, HCT116 and HCT116-HM cells are presented, n = 3 biologically independent experiments. Scale bar, 50 μm. G-J Representative metastatic livers gross morphology from NOD/SCID mice intrasplenically implanted with LoVo, LoVo-HM, HCT116 or HCT116-HM cells (n = 5 per group). K Western blot analysis of SPP1 protein levels in LoVo, LoVo-HM, HCT116, and HCT116-HM cells, n = 3 biologically independent experiments. L Expression of SPP1 gene in different cancer and normal tissues of TIMER2.0 database. M, N Association of SPP1 expression with OS (M) and DFS (N) in CRC based on TCGA data. O-Q Correlation of SPP1 expression with pathological stage, N stage and T stage in CRC patients. All results are presented as mean ± SEM. The data in M, N were determined by Kaplan–Meier analysis with the log-rank test. P values were determined by two-tailed unpaired Student’s t test (C-F, H, J, P) and one-way ANOVA (O, Q). **P < 0.01, ***P < 0.001.
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S1 Verification of high-metastasis mouse model and the relationship between SPP1 and clinical features. A-F Results of bright field imaging, migration, and invasion assays for LoVo, LoVo-HM, HCT116 and HCT116-HM cells are presented, n = 3 biologically independent experiments. Scale bar, 50 μm. G-J Representative metastatic livers gross morphology from NOD/SCID mice intrasplenically implanted with LoVo, LoVo-HM, HCT116 or HCT116-HM cells (n = 5 per group). K Western blot analysis of SPP1 protein levels in LoVo, LoVo-HM, HCT116, and HCT116-HM cells, n = 3 biologically independent experiments. L Expression of SPP1 gene in different cancer and normal tissues of TIMER2.0 database. M, N Association of SPP1 expression with OS (M) and DFS (N) in CRC based on TCGA data. O-Q Correlation of SPP1 expression with pathological stage, N stage and T stage in CRC patients. All results are presented as mean ± SEM. The data in M, N were determined by Kaplan–Meier analysis with the log-rank test. P values were determined by two-tailed unpaired Student’s t test (C-F, H, J, P) and one-way ANOVA (O, Q). **P < 0.01, ***P < 0.001.
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S6 Talabostat mesylate reverses the progression of CRLM and synergizes with PD-1 blockade therapy A-C Collagen content assessed by Masson’s trichrome staining, and expression levels of α-SMA and CD8 evaluated by mIHC analysis. D, E Ki-67 and TUNEL staining were performed on PDOX tumor tissues to evaluate cell apoptosis and proliferation. F H&E analysis in tumor tissues from each group. G Flow cytometry validated the engraftment of hCD45+ cells 14 days post implantation in each group of mice (n = 3/group). H Collagen content was assessed using Masson’s trichrome staining, while expression levels of α-SMA and CD8 were evaluated through mIHC analysis. Ki-67 and TUNEL staining were performed on PDX tumor tissues to assess cell apoptosis and proliferation. H&E analysis was conducted on tumor tissues from each group. I, J Collagen content assessed by Masson’s trichrome staining, and expression levels of α-SMA evaluated by IHC analysis. IOD: Integrated Optical Density. K TUNEL staining was performed to evaluate cell apoptosis. All results are presented as mean ± SEM. P values were determined by one-way ANOVA. **P < 0.01, ***P < 0.001.
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S6 Talabostat mesylate reverses the progression of CRLM and synergizes with PD-1 blockade therapy A-C Collagen content assessed by Masson’s trichrome staining, and expression levels of α-SMA and CD8 evaluated by mIHC analysis. D, E Ki-67 and TUNEL staining were performed on PDOX tumor tissues to evaluate cell apoptosis and proliferation. F H&E analysis in tumor tissues from each group. G Flow cytometry validated the engraftment of hCD45+ cells 14 days post implantation in each group of mice (n = 3/group). H Collagen content was assessed using Masson’s trichrome staining, while expression levels of α-SMA and CD8 were evaluated through mIHC analysis. Ki-67 and TUNEL staining were performed on PDX tumor tissues to assess cell apoptosis and proliferation. H&E analysis was conducted on tumor tissues from each group. I, J Collagen content assessed by Masson’s trichrome staining, and expression levels of α-SMA evaluated by IHC analysis. IOD: Integrated Optical Density. K TUNEL staining was performed to evaluate cell apoptosis. All results are presented as mean ± SEM. P values were determined by one-way ANOVA. **P < 0.01, ***P < 0.001.
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Plasma SPP1-stratified demographic features of 156 GC patients treated with ICBs.
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Plasma SPP1-stratified demographic features of 156 GC patients treated with ICBs.
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S8 High plasma SPP1 levels are associated with poor response to immunotherapy in GC patients. A, B Statistical analysis of irOS (A) and irPFS (B) in the SPP1 lower and SPP1 higher groups. C-F Statistical analysis of the best treatment efficacy results in the SPP1 lower and SPP1 higher groups. Data in scatter plots indicate mean ± SEM. ***P < 0.001. Log-rank test (A, B), Student’s t test (C-E), one-way ANOVA (F). CR, Complete Response; PR, Partial Response; PD, Progressive Disease; SD, Stable Disease; irOS, immune-related Overall Survival; irPFS, immune-related Progression-Free Survival; ORR, Objective Response Rate; DCR, Disease Control Rate.
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S8 High plasma SPP1 levels are associated with poor response to immunotherapy in GC patients. A, B Statistical analysis of irOS (A) and irPFS (B) in the SPP1 lower and SPP1 higher groups. C-F Statistical analysis of the best treatment efficacy results in the SPP1 lower and SPP1 higher groups. Data in scatter plots indicate mean ± SEM. ***P < 0.001. Log-rank test (A, B), Student’s t test (C-E), one-way ANOVA (F). CR, Complete Response; PR, Partial Response; PD, Progressive Disease; SD, Stable Disease; irOS, immune-related Overall Survival; irPFS, immune-related Progression-Free Survival; ORR, Objective Response Rate; DCR, Disease Control Rate.
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S5 SPP1-CD44 interaction activates β-catenin/HIF-1α signaling in CAFs. A GSEA analysis of RNA-seq data from CAFs derived from primary tumors (PT-CAFs) and liver metastases (LM-CAFs) of CRC patients. B qRT-PCR and western blot assessed the knockdown efficiency of si-CTNNB1 in CAFs. C qRT-PCR was used to evaluate the mRNA expression of HIF1A in CAFs with CTNNB1 knockdown (left) or MSAB treatment (right), n = 3 biologically independent experiments. D Western blot analysis was performed to assess the protein expression of HIF-1α in CAFs with CTNNB1 knockdown or MSAB treatment. E qRT-PCR and western blot assessed the knockdown efficiency of si-HIF1A in CAFs. F qRT-PCR was used to measure CD44 mRNA levels in T cells and different kind of CAFs. NAF: normal-associated fibroblasts; PT: primary tumor; LM: liver metastasis, n = 3 biologically independent experiments. G qRT-PCR and western blot assessed the knockdown efficiency of si-CD44 in CAFs. H, I Western blot analysis was conducted to evaluate HIF-1α and β-catenin protein expression in control (si-NC) and CD44 knockdown CAFs, with or without conditional medium from HCT116-HM (H) or LOVO-HM (I). J CAF cells were transfected with si-NC or si-CD44 and subsequently treated with conditioned medium from SPP1-overexpressing HCT116 or LoVo cells. The expression levels of β-catenin and HIF-1α were then assessed by western blot. K Western blot analysis was conducted to evaluate HIF-1α and β-catenin protein expression in control (si-NC) and CD44 knockdown CAFs, with or without rhSPP1 protein (1 µg/mL) treatment. L Nuclear-cytoplasmic fractionation was performed to assess the nuclear translocation of HIF-1α in control (si-NC) and CD44 knockdown CAFs, with or without treatment with rhSPP1 protein (1 µg/mL). Western blot experiments in (A, C, F-J) were repeated three times, the data are representative of three biologically independent experiments. All results are presented as mean ± SEM. P values were determined by two-tailed unpaired Student’s t test (C) and one-way ANOVA (B, E-G). ns, no significant difference, **P < 0.01, ***P < 0.001.
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Figure S5 SPP1-CD44 interaction activates β-catenin/HIF-1α signaling in CAFs. A GSEA analysis of RNA-seq data from CAFs derived from primary tumors (PT-CAFs) and liver metastases (LM-CAFs) of CRC patients. B qRT-PCR and western blot assessed the knockdown efficiency of si-CTNNB1 in CAFs. C qRT-PCR was used to evaluate the mRNA expression of HIF1A in CAFs with CTNNB1 knockdown (left) or MSAB treatment (right), n = 3 biologically independent experiments. D Western blot analysis was performed to assess the protein expression of HIF-1α in CAFs with CTNNB1 knockdown or MSAB treatment. E qRT-PCR and western blot assessed the knockdown efficiency of si-HIF1A in CAFs. F qRT-PCR was used to measure CD44 mRNA levels in T cells and different kind of CAFs. NAF: normal-associated fibroblasts; PT: primary tumor; LM: liver metastasis, n = 3 biologically independent experiments. G qRT-PCR and western blot assessed the knockdown efficiency of si-CD44 in CAFs. H, I Western blot analysis was conducted to evaluate HIF-1α and β-catenin protein expression in control (si-NC) and CD44 knockdown CAFs, with or without conditional medium from HCT116-HM (H) or LOVO-HM (I). J CAF cells were transfected with si-NC or si-CD44 and subsequently treated with conditioned medium from SPP1-overexpressing HCT116 or LoVo cells. The expression levels of β-catenin and HIF-1α were then assessed by western blot. K Western blot analysis was conducted to evaluate HIF-1α and β-catenin protein expression in control (si-NC) and CD44 knockdown CAFs, with or without rhSPP1 protein (1 µg/mL) treatment. L Nuclear-cytoplasmic fractionation was performed to assess the nuclear translocation of HIF-1α in control (si-NC) and CD44 knockdown CAFs, with or without treatment with rhSPP1 protein (1 µg/mL). Western blot experiments in (A, C, F-J) were repeated three times, the data are representative of three biologically independent experiments. All results are presented as mean ± SEM. P values were determined by two-tailed unpaired Student’s t test (C) and one-way ANOVA (B, E-G). ns, no significant difference, **P < 0.01, ***P < 0.001.